There's an old adage in biotech that says you raise money when you can,
regardless of whether you really need it at the moment. With very strong
early-stage data in hand on lead compound ALN-TTR02, Alnylam
Pharmaceuticals (ALNY) may well be considering whether it is time to raise money again.
Please read more here:
Will Alnylam Raise Money Soon?
No comments:
Post a Comment